D. Fearon

2.5k total citations
15 papers, 395 citations indexed

About

D. Fearon is a scholar working on Molecular Biology, Infectious Diseases and Materials Chemistry. According to data from OpenAlex, D. Fearon has authored 15 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Materials Chemistry. Recurrent topics in D. Fearon's work include Enzyme Structure and Function (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Click Chemistry and Applications (3 papers). D. Fearon is often cited by papers focused on Enzyme Structure and Function (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Click Chemistry and Applications (3 papers). D. Fearon collaborates with scholars based in United Kingdom, South Africa and Canada. D. Fearon's co-authors include F. von Delft, A. Douangamath, J. Brandão-Neto, Louise Dunnett, T.J. Gorrie-Stone, R. Skyner, O. Gileadi, J.A. Newman, Matthieu Schapira and A. Aimon and has published in prestigious journals such as Nature Communications, Journal of Molecular Biology and Journal of Medicinal Chemistry.

In The Last Decade

D. Fearon

12 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Fearon United Kingdom	8	195	157	148	79	48	15	395
Lovika Mittal India	12	164 0.8×	214 1.4×	136 0.9×	61 0.8×	19 0.4×	18	388
Hui-Chuan Chang Taiwan	9	254 1.3×	200 1.3×	275 1.9×	45 0.6×	55 1.1×	16	499
Min‐Feng Hsu Taiwan	7	159 0.8×	156 1.0×	215 1.5×	40 0.5×	23 0.5×	14	384
Mitul Srivastava India	12	195 1.0×	224 1.4×	154 1.0×	62 0.8×	22 0.5×	26	429
Olivier Sheik Amamuddy South Africa	13	362 1.9×	188 1.2×	133 0.9×	29 0.4×	47 1.0×	16	503
M.G. Deshmukh United States	8	303 1.6×	325 2.1×	232 1.6×	110 1.4×	39 0.8×	9	597
Eric M. Lewandowski United States	11	148 0.8×	79 0.5×	175 1.2×	107 1.4×	22 0.5×	18	417
Matteo Pavan Italy	14	303 1.6×	171 1.1×	154 1.0×	122 1.5×	16 0.3×	34	537
M.M. Kashipathy United States	10	184 0.9×	232 1.5×	282 1.9×	84 1.1×	19 0.4×	23	503
Tika R. Malla United Kingdom	12	178 0.9×	186 1.2×	163 1.1×	120 1.5×	18 0.4×	16	407

Countries citing papers authored by D. Fearon

Since Specialization

Citations

This map shows the geographic impact of D. Fearon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Fearon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Fearon more than expected).

Fields of papers citing papers by D. Fearon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Fearon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Fearon. The network helps show where D. Fearon may publish in the future.

Co-authorship network of co-authors of D. Fearon

This figure shows the co-authorship network connecting the top 25 collaborators of D. Fearon. A scholar is included among the top collaborators of D. Fearon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Fearon. D. Fearon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Schwalm, Martin P., Krishna Saxena, Thomas Hanke, et al.. (2025). Crystallographic fragment screening reveals ligand hotspots in TRIM21 PRY-SPRY domain. Communications Chemistry. 8(1). 185–185.

Erlanson, Daniel A., S.K. Burley, D. Fearon, et al.. (2025). Where and how to house big data on small fragments. Nature Communications. 16(1). 4179–4179. 4 indexed citations

Saini, Manisha, et al.. (2025). Crystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside Antiflavivirals. Journal of Medicinal Chemistry. 68(17). 18356–18369.

Kot, Eva, Matteo P. Ferla, Charles W.E. Tomlinson, et al.. (2025). Crystal structure of fatty acid thioesterase A bound by 129 fragments provides diverse development opportunities. Pest Management Science. 82(1). 151–168.

Beelen, Steven, Vanda Lux, D. Fearon, et al.. (2024). Rational fragment-based design of compounds targeting the PWWP domain of the HRP family. European Journal of Medicinal Chemistry. 280. 116960–116960. 5 indexed citations

Schuller, M., Tryfon Zarganes‐Tzitzikas, James M. Bennett, et al.. (2023). Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors. Pathogens. 12(2). 324–324. 11 indexed citations

Chenthamarakshan, Vijil, Samuel C. Hoffman, David Owen, et al.. (2023). Accelerating drug target inhibitor discovery with a deep generative foundation model. Science Advances. 9(25). eadg7865–eadg7865. 22 indexed citations

Beelen, Steven, D. Fearon, A. Douangamath, et al.. (2022). Discovery of novel druggable pockets on polyomavirus VP1 through crystallographic fragment-based screening to develop capsid assembly inhibitors. RSC Chemical Biology. 3(8). 1013–1027. 1 indexed citations

Roe, S. Mark, et al.. (2022). Synthesis of a Thiazole Library via an Iridium-Catalyzed Sulfur Ylide Insertion Reaction. Organic Letters. 24(43). 7924–7927. 23 indexed citations

10.

Newman, J.A., A. Douangamath, Y. Yosaatmadja, et al.. (2021). Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase. Nature Communications. 12(1). 4848–4848. 155 indexed citations

11.

Noske, G.D., A.M. Nakamura, Victor O. Gawriljuk, et al.. (2021). A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process. Journal of Molecular Biology. 433(18). 167118–167118. 44 indexed citations

12.

Bajusz, Dávid, Warren S. Wade, Grzegorz Satała, et al.. (2021). Exploring protein hotspots by optimized fragment pharmacophores. Nature Communications. 12(1). 3201–3201. 31 indexed citations

13.

Douangamath, A., A.J. Powell, D. Fearon, et al.. (2021). Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source. Journal of Visualized Experiments. 40 indexed citations

14.

Zaidman, Daniel, Paul Gehrtz, D. Fearon, et al.. (2021). An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor. Cell chemical biology. 28(12). 1795–1806.e5. 52 indexed citations

15.

Fearon, D., Isaac M. Westwood, Rob L. M. van Montfort, et al.. (2018). Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition. Bioorganic & Medicinal Chemistry. 26(11). 3021–3029. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact